Фещенко Д. А., Руденко Б. А., Драпкина О. М., Гаврилова Н. Е., Шаноян А. С., Шукуров Ф. Б., Васильев Д. К. Клинический случай радиочастотной денервации легочного ствола при резидуальной хронической тромбоэмболической легочной гипертензии. Кардиоваскулярная терапия и профилактика. 2019;18(6):121-125.
https://doi.org/10.15829/1728-8800-2019-6-121-125
1. Galie N, Hoeper M, Humbert M, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society. Eur Heart J. 2016;37:67-119. doi:10.1093/eurheartj/ehv317.
2. Lang IM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulaion. 2006;113:2011-20. doi:10.1161/CIRCULATIONAHA.105.602565.
3. Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33:325-31. doi:10.1183/09031936.00087608.
4. Condliffe R, Kiely DG, Gibbs JS, Corris PA, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122-7. doi:10.1164/rccm.200712-1841OC.
5. Bhama-Ariza P, Keogh AM, Muller DW. Percutaneus interventional therapies for the treatment of patients with severe pulmonary hypertension. JACC. 2014;63:611-8. doi:10.1016/j.jacc.2013.11.022.
6. Verity MA, Bevan JA. Fine structural study of the terminal effector plexus, neuromuscular and intermuscular relationships in the pulmonary artery. J Anat. 1968;103(1):49-63.
7. Richardson JB. Nerve supply to the lungs. Am Rev Respir Dis. 1979;119(5):785-802.
8. Chen SL, Zhang YJ, Zhou L, et al. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention. 2013;9(2):269-76. doi:10.4244/EIJV9I2A43.
9. Chen SL, Zhang H, Xie DJ, et al. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 Study. Circ Cardiovasc Interv. 2015;8:e002837. doi:10.1161/CIRCINTERVENTIONS.115.002837.